Material World: Spinnova Collaborator Forms Joint Venture With IFF

In This Article:

Material World is a weekly roundup of innovations and ideas within the materials sector, covering news from emerging biomaterials and alternative leathers to sustainable substitutes and future-proof fibers.

IFF x Kemira

Joint venture Alpha Bio will use IFF’s proprietary Designed Enzymatic Biomaterials technology to provide greener alternatives to fossil-based ingredients.
Joint venture Alpha Bio will use IFF’s proprietary Designed Enzymatic Biomaterials technology to provide greener alternatives to fossil-based ingredients.

International Flavors & Fragrances (IFF) and global chemical company Kemira—which previously entered into a long-term collaboration with Spinnova in 2020—have formed a joint venture for the commercial-scale production of renewable biobased materials.

More from Sourcing Journal

Dubbed Alpha Bio, the venture received an investment of approximately $140 million (130 million euros) to convert up to 44,000 metric tons of plant sugars into bioproducts, with the Alpha Bio facility set to start production in late 2027, seemingly at the IFF’s biorefinery in Kotka, Finland.

“Operating as an independent entity in Kotka, Finland, the joint venture will manufacture a specific line of products enabled by [Designed Enzymatic Biomaterials] technology for exclusive use by IFF and Kemira,” a company statement reads. “The creation of Alpha Bio is expected to generate approximately 30 direct new jobs in the Kotka area with additional job creation during the project’s construction phase.”

With a strong industrial base along the Kemijoki River, according to Kotka’s business website, the city’s port is a major hub for exports to the wood, paper and pulp industries. Google’s data center in the nearby Hamina helped pique the interest of more digitalized industries, including cleantech and the bioeconomy.

The facility’s outputs—including “high-performance” biopolymers—will serve several sectors, including home, personal care and industrial solutions. The Alpha Bio venture will use IFF’s Designed Enzymatic Biomaterials (DEB) platform technology as integrated at its aforementioned biorefinery.

“Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers,” said Erik Fyrwald, CEO of IFF. “IFF’s DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also enhances performance across various applications. This innovative approach allows us to combine biodegradability and material sustainability while maintaining cost efficiency and the high performance our customers expect.”